The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma
- PMID: 28300695
- PMCID: PMC5474177
- DOI: 10.1016/j.cgh.2017.03.003
The Countdown to a Paradigm Shift in Diagnosing Pancreatic Ductal Adenocarcinoma
Conflict of interest statement
Comment on
-
Increasing Number of Passes Beyond 4 Does Not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine-Needle Aspiration.Clin Gastroenterol Hepatol. 2017 Jul;15(7):1071-1078.e2. doi: 10.1016/j.cgh.2016.12.018. Epub 2016 Dec 23. Clin Gastroenterol Hepatol. 2017. PMID: 28025154 Clinical Trial.
References
-
- Wani S, Wallace MB, Cohen J, et al. Quality indicators for EUS. Gastrointest Endosc. 2015;81:67–80. - PubMed
-
- Brand RE, Adai AT, Centeno BA, et al. A microRNA-based test improves endoscopic ultrasound-guided cytologic diagnosis of pancreatic cancer. Clin Gastroenterol Hepatol. 2014;12:1717–23. - PubMed
-
- Wani S, Mullady D, Early DS, et al. The clinical impact of immediate on-site cytopathology evaluation during endoscopic ultrasound-guided fine needle aspiration of pancreatic masses: a prospective multicenter randomized controlled trial. Am J Gastroenterol. 2015;110:1429–39. - PubMed
-
- Mohamadnejad M, Mullady D, Early DS, et al. Increasing Number of Passes Beyond 4 Does not Increase Sensitivity of Detection of Pancreatic Malignancy by Endoscopic Ultrasound-Guided Fine Needle Aspiration. Clin Gastroenterol Hepatol. 2016 - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
